Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection.
about
Optimum duration of regimens for Helicobacter pylori eradicationOptimum duration of regimens for Helicobacter pylori eradicationEradication therapy for peptic ulcer disease in Helicobacter pylori positive patientsH pylori antibiotic resistance: prevalence, importance, and advances in testingRole of rapid urease test and histopathology in the diagnosis of Helicobacter pylori infection in a developing countryDiagnostic Methods of Helicobacter pylori Infection for Epidemiological Studies: Critical Importance of Indirect Test ValidationOmega-3 Polyunsaturated Fatty Acids Intake to Regulate Helicobacter pylori-Associated Gastric Diseases as Nonantimicrobial Dietary ApproachSecond and third line treatment options for Helicobacter pylori eradicationGastric cancer: prevention, screening and early diagnosisDiagnosis, treatment, and outcome in patients with bleeding peptic ulcers and Helicobacter pylori infectionsCurrent concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus ReportAntibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcomeManagement of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade PortuProteome analysis of highly immunoreactive proteins of Helicobacter pylori.A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China.One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance.Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infectionShort-term triple therapy with azithromycin for Helicobacter pylori eradication: low cost, high compliance, but low efficacyHematologic manifestations of Helicobacter pylori infectionTreating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.Helicobacter pylori eradication for preventing gastric cancerHow should Helicobacter pylori positive dyspeptic patients be managed?Treatment after failure: the problem of "non-responders".Validity and cost comparison of 14carbon urea breath test for diagnosis of H Pylori in dyspeptic patients.Omeprazole-based triple therapy with low-versus high-dose of clarithromycin plus amoxicillin for H pylori eradication in Iranian populationDiscrepancies between primary physician practice and treatment guidelines for Helicobacter pylori infection in Korea.A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection.Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori.Review article: Helicobacter pylori and nonulcer dyspepsia.Structural basis for shikimate-binding specificity of Helicobacter pylori shikimate kinase.Clarithromycin for Helicobacter pylori infection.Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile.Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection.Review article: should we kill or should we save Helicobacter pylori?Eradication of helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stoneImproving compliance with helicobacter pylori eradication therapy: when and how?Second-line rescue therapy of helicobacter pylori infection.A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule.Management of uninvestigated dyspepsia: review and commentary.Dyspepsia: management guidelines for the millennium.
P2860
Q24201841-731E67F2-D0B0-4575-8A3E-466FFB025044Q24241402-FD304C95-925A-4981-AC9E-8A38CF50CAD6Q24246267-2F7C13A7-55DE-4E4C-85A5-1929239F73DCQ24685864-3AC5C0FD-2B4E-4F34-8706-F04A7B823F06Q24813062-F09F895E-1AF3-4AC2-B4D3-9EC6FA80819BQ26767158-553E00FF-B403-48E1-BBC6-EB5774EA35E5Q26784466-3F536A7C-AEF1-4EC6-811B-9CD9F9ACE8D5Q26829666-313410D9-ADA6-4BA0-872A-E32939F82DE1Q26860418-BAE4493F-F84B-4DCA-AF03-33EBFDB981FCQ27027870-931C4F0E-647B-4472-809B-0BA3B7B36CD6Q28203195-DB63CBE2-F14E-4619-AA25-C06880ACE99CQ28363415-1E824848-8041-40D3-AAD2-17B6228464D7Q30426539-4CAA0FFC-920B-4B7C-A2B6-37FED6D06BDEQ31067940-FBA3225B-15AF-451E-8D96-7CFC7EB759B5Q31795206-F8042DDD-B7EB-4971-A584-E164553B4E9FQ32026717-85CDD2E3-0F0E-44BA-AE28-FA7769D4DEC1Q33291670-C51A2A73-4230-4908-9EB0-269E9634FEBDQ33338688-28BD83BD-AEC1-4348-B1DA-44E833648020Q33417972-E7BF59F0-3D45-4E72-8C84-AE9C81104839Q33619652-A65ECD1B-4FE4-428A-B99E-706EA08EDF5AQ33626785-FA50710B-BDA7-4B49-8483-EF53FC6F4BAAQ33717345-C90D6083-DD45-4124-8A53-EA9757DACD21Q33717362-E257EFDF-EF07-421E-B6A4-BE52F01E5C58Q33787761-CF593A52-393E-4D07-9256-BD1C639C020DQ33787766-37FC35E0-5172-40D6-BFB9-687C742EDFA8Q33829922-A9784280-B819-4064-8A19-FD696A444B30Q33904326-CC8ADF2C-27B6-4780-8D72-7B9B6B9207A0Q34049805-6C3B1D3B-46F7-47EB-95E1-D1A690C30412Q34114492-445FDBCC-56A4-45D1-AA7C-6EBA1474622DQ34150938-C7E6395C-A6C0-4335-84F5-ADB67520ED03Q34182199-EAB94071-0D61-4BB4-98DD-B3FF9F8B00B3Q34224762-C0B2E20B-A8C3-43F6-8089-1FB18A65CDB0Q34291666-0DB7455B-17B9-4BCE-9C54-6513E188DB98Q34327982-3618A585-5BE9-4A51-92A2-E9357A04F1C7Q34408895-B8F29D6A-8DF8-4168-B435-921906B734D2Q34409052-F15A3DCE-C3CC-4B37-94AD-C56DAEF13BA5Q34409114-58745997-29BD-4CC3-B0B8-61C848500A10Q34481671-1B6FA1E3-FD66-4907-B48C-72E7020C5348Q34601069-FA798461-BBF2-4DF5-9FDC-0910F133B850Q34601100-FD451304-8BFE-4D7C-9965-389DF357AF69
P2860
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Report of the 1997 Asia Pacifi ...... Helicobacter pylori infection.
@en
Report of the 1997 Asia Pacifi ...... Helicobacter pylori infection.
@nl
type
label
Report of the 1997 Asia Pacifi ...... Helicobacter pylori infection.
@en
Report of the 1997 Asia Pacifi ...... Helicobacter pylori infection.
@nl
prefLabel
Report of the 1997 Asia Pacifi ...... Helicobacter pylori infection.
@en
Report of the 1997 Asia Pacifi ...... Helicobacter pylori infection.
@nl
P2860
P1476
Report of the 1997 Asia Pacifi ...... Helicobacter pylori infection.
@en
P2093
P2860
P356
10.1111/J.1440-1746.1998.TB00537.X
P577
1998-01-01T00:00:00Z